TY  - GEN
AU  - Lainez, Nuria
AU  - Garcia-Donas, Jesus
AU  - Esteban, Emilio
AU  - Puente, Javier
AU  - Isabel Saez, M
AU  - Gallardo, Enrique
AU  - Pinto-Marin, Alvaro
AU  - Vazquez-Estevez, Sergio
AU  - Leon, Luis
AU  - Garcia-Carbonero, Icar
AU  - Suarez-Rodriguez, Cristina
AU  - Molins, Carmen
AU  - Climent-Duran, Miguel A
AU  - Lazaro-Quintela, Martin
AU  - Gonzalez del Alba, Aranzazu
AU  - Jose Mendez-Vidal, Maria
AU  - Chirivella, Isabel
AU  - Afonso, Francisco J
AU  - Lopez-Brea, Marta
AU  - Sala-Gonzalez, Nuria
AU  - Domenech, Montserrat
AU  - Basterretxea, Laura
AU  - Santander-Lobera, Carmen
AU  - Gil-Arnaiz, Irene
AU  - Fernandez, Ovidio
AU  - Caballero-Diaz, Cristina
AU  - Mellado, Begona
AU  - Marrupe, David
AU  - Garcia-Sanchez, Jose
AU  - Sanchez-Escribano, Ricardo
AU  - Fernandez Parra, Eva
AU  - Villa Guzman, Jose C
AU  - Martinez-Ortega, Esther
AU  - Belen Gonzalez, Maria
AU  - Moran, Marina
AU  - Suarez-Paniagua, Beatriz
AU  - Lecumberri, Maria J
AU  - Castellano, Daniel
PY  - 2016
DO  - 10.1186/s12885-016-2084-9
UR  - http://hdl.handle.net/20.500.12105/20251
AB  - Background: The impact of such recommendations after their implementation of guidelines has not usually been evaluated. Herein, we assessed the impact and compliance with the Spanish Oncology Genitourinary Group (SOGUG) Guidelines for toxicity...
LA  - eng
PB  - BioMed Central (BMC)
KW  - Adverse events
KW  - Guidelines
KW  - Renal cell carcinoma
KW  - Targeted therapy
KW  - Aged
KW  - Spain
KW  - Humans
KW  - Antineoplastic Agents
KW  - Middle Aged
KW  - Carcinoma, Renal Cell
KW  - Male
KW  - Molecular Targeted Therapy
KW  - Kidney Neoplasms
KW  - Neoplasm Metastasis
KW  - Female
KW  - Guideline Adherence
KW  - Practice Guidelines as Topic
TI  - Impact on clinical practice of the implementation of guidelines for the toxicity management of targeted therapies in kidney cancer. The protect-2 study
TY  - research article
ER  -